chr5-178991554-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000843.4(GRM6):​c.727G>T​(p.Val243Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0037 in 1,612,786 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0032 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 40 hom. )

Consequence

GRM6
NM_000843.4 missense

Scores

14
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 0.841
Variant links:
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015617073).
BP6
Variant 5-178991554-C-A is Benign according to our data. Variant chr5-178991554-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 99657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-178991554-C-A is described in Lovd as [Likely_benign]. Variant chr5-178991554-C-A is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00317 (482/152070) while in subpopulation SAS AF= 0.0145 (70/4814). AF 95% confidence interval is 0.0118. There are 7 homozygotes in gnomad4. There are 248 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GRM6NM_000843.4 linkuse as main transcriptc.727G>T p.Val243Phe missense_variant 4/11 ENST00000517717.3 NP_000834.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GRM6ENST00000517717.3 linkuse as main transcriptc.727G>T p.Val243Phe missense_variant 4/115 NM_000843.4 ENSP00000430767 P1
GRM6ENST00000231188.9 linkuse as main transcriptc.727G>T p.Val243Phe missense_variant 3/102 ENSP00000231188 P1
GRM6ENST00000650031.1 linkuse as main transcriptc.727G>T p.Val243Phe missense_variant 5/12 ENSP00000497110 P1

Frequencies

GnomAD3 genomes
AF:
0.00319
AC:
485
AN:
151954
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000556
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.0421
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.0145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00275
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00502
AC:
1261
AN:
251300
Hom.:
7
AF XY:
0.00568
AC XY:
772
AN XY:
135838
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00156
Gnomad ASJ exome
AF:
0.0380
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0128
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00323
Gnomad OTH exome
AF:
0.00848
GnomAD4 exome
AF:
0.00376
AC:
5492
AN:
1460716
Hom.:
40
Cov.:
33
AF XY:
0.00420
AC XY:
3050
AN XY:
726710
show subpopulations
Gnomad4 AFR exome
AF:
0.000329
Gnomad4 AMR exome
AF:
0.00165
Gnomad4 ASJ exome
AF:
0.0377
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0134
Gnomad4 FIN exome
AF:
0.000431
Gnomad4 NFE exome
AF:
0.00253
Gnomad4 OTH exome
AF:
0.00565
GnomAD4 genome
AF:
0.00317
AC:
482
AN:
152070
Hom.:
7
Cov.:
32
AF XY:
0.00333
AC XY:
248
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.000554
Gnomad4 AMR
AF:
0.00281
Gnomad4 ASJ
AF:
0.0421
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.0145
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00274
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.00459
Hom.:
13
Bravo
AF:
0.00294
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00463
AC:
562
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.00474
EpiControl
AF:
0.00492

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
not provided, no classification providedliterature onlyRetina International-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 26, 2024- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024GRM6: BS1, BS2 -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 26, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 25, 2016- -
Congenital stationary night blindness 1B Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 27, 2022- -
GRM6-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 09, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D;D;D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.96
D;.;.
MetaRNN
Benign
0.016
T;T;T
MetaSVM
Uncertain
0.65
D
MutationAssessor
Uncertain
2.4
M;M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.6
D;D;.
REVEL
Uncertain
0.60
Sift
Uncertain
0.0010
D;D;.
Sift4G
Uncertain
0.0040
D;D;.
Polyphen
0.98
D;D;D
Vest4
0.77
MVP
0.88
MPC
0.45
ClinPred
0.035
T
GERP RS
5.2
Varity_R
0.62
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17078894; hg19: chr5-178418555; COSMIC: COSV99039548; COSMIC: COSV99039548; API